BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38413784)

  • 1. MicroRNA-203a inhibits breast cancer progression through the PI3K/Akt and Wnt pathways.
    Entezari M; Soltani BM; Sadeghizadeh M
    Sci Rep; 2024 Feb; 14(1):4715. PubMed ID: 38413784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-203a-3p targets PTEN to promote hepatocyte proliferation by regulating PI3K/Akt pathway in BRL-3A cells.
    Zhang Y; Zheng Y; Zhu G
    Biosci Biotechnol Biochem; 2020 Apr; 84(4):725-733. PubMed ID: 31814541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
    J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel long non-coding RNA XLOC_004787, is associated with migration and promotes cancer cell proliferation by downregulating mir-203a-3p in gastric cancer.
    Miao R; Yao Z; Hu B; Jin T; Zhu D; Shi Y; Gong Y; Shao S; Shao C
    BMC Gastroenterol; 2023 Aug; 23(1):280. PubMed ID: 37573302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
    Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
    Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway.
    Zhang Y; Li S; Cui X; Wang Y
    Apoptosis; 2023 Dec; 28(11-12):1546-1563. PubMed ID: 37486406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.
    Li Q; Liu J; Jia Y; Li T; Zhang M
    Aging (Albany NY); 2020 Jun; 12(11):10246-10258. PubMed ID: 32501811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
    Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
    Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel splice variants of LINC00963 suppress colorectal cancer cell proliferation via miR-10a/miR-143/miR-217/miR-512-mediated regulation of PI3K/AKT and Wnt/β-catenin signaling pathways.
    Ghaemi Z; Mowla SJ; Soltani BM
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194921. PubMed ID: 36804476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a.
    Wang Y; Kong D
    Cell Physiol Biochem; 2018; 45(2):844-855. PubMed ID: 29414815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
    Liu C; Liu Z; Li X; Tang X; He J; Lu S
    Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.
    Poodineh J; Sirati-Sabet M; Rajabibazl M; Ghasemian M; Mohammadi-Yeganeh S
    Chem Biol Drug Des; 2022 Sep; 100(3):334-345. PubMed ID: 35797350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
    Liu Y; Yang H
    Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
    Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
    Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu).
    Gao X; Fan X; Zeng W; Liang J; Guo N; Yang X; Zhao Y
    Bioengineered; 2022 Mar; 13(3):7881-7893. PubMed ID: 35294329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
    Fan L; Cao X; Lei Y
    Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
    Shi L; Kan J; Zhuo L; Wang S; Chen S; Zhang B; Ke B
    FEBS J; 2023 Feb; 290(4):1134-1150. PubMed ID: 36180981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.